Sign in
4

Changes in Ownership

LB PHARMACEUTICALS INC Filed Acc 0001304340-25-000006

Options or other derivatives

  • Senior Vice President, Finance acquired 118,134 shares (grant or award)
  • Senior Vice President, Finance returned 27,609 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Returned to the company · Employee Stock Option (Right to Buy) −3,944 0 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Grant or award · Employee Stock Option (Right to Buy) +3,944 3,944 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Returned to the company · Employee Stock Option (Right to Buy) −896 0 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Grant or award · Employee Stock Option (Right to Buy) +896 896 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Returned to the company · Employee Stock Option (Right to Buy) −1,255 0 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Grant or award · Employee Stock Option (Right to Buy) +1,255 1,255 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Returned to the company · Employee Stock Option (Right to Buy) −14,343 0 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Grant or award · Employee Stock Option (Right to Buy) +14,343 14,343 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Returned to the company · Employee Stock Option (Right to Buy) −7,171 0 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Grant or award · Employee Stock Option (Right to Buy) +7,171 7,171 D
PANOFF MARC L Senior Vice President, Finance 2025-09-10 Grant or award · Employee Stock Option (Right to Buy) +90,525 90,525 D
Loading xslF345X05/form4-09302025_120930.xml…